SUBMIT YOUR RESEARCH
Saudi Journal of Medicine (SJM)
Volume-7 | Issue-09 | 501-504
Case Report
Vesiculo-Bullous Eruption Following COVID Vaccination
Raghda Saeed Al Maashari, Al Mahmood Noaf S, Saleem Tausif
Published : Sept. 23, 2022
DOI : 10.36348/sjm.2022.v07i09.007
Abstract
Bullous pemphigoid (BP) is an autoimmune sub-epidermal bullous disorder with a complex etiopathogenesis, predominately affecting the elderly. We report a case of COVID vaccination- induced BP, in a 30-year-old previously healthy Indian male who presented with a 1month history of itchy generalized vesiculo-bullous eruption that developed 3 days after receiving the first dose of the COVID vaccination. Histological examination and direct immunofluorescence study showed a sub-epidermal blister with a dermal inflammatory infiltrate and linear epidermal staining of IgG and C3 along the basement membrane zone in an n-serrated pattern. Treatment with oral prednisolone and oral doxycycline resulted in significant improvement in his condition. To our knowledge, there are limited case reports to date particularly in the Middle-East, which describe BP triggered by COVID vaccination.
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.